头孢他啶-阿维巴坦、美罗培南-巴坦和普拉佐米星对多重耐药菌的抗菌活性——一项保加利亚的试点研究 - Suppr

Antimicrobial activities of ceftazidime-avibactam, meropenem-vaborbactam and plazomicin against multidrug-resistant and - a pilot Bulgarian study.

作者信息

Savov Encho, Trifonova Angelina, Kovachka Krassimira, Kjosseva Elena, Strateva Tanya

机构信息

Laboratory of Microbiology, Department of Military Epidemiology and Hygiene, Military Medical Academy , Sofia , Bulgaria.

Multiprofile Hospital for Active Treatment , Samokov , Bulgaria.

出版信息

Infect Dis (Lond). 2019 Nov-Dec;51(11-12):870-873. doi: 10.1080/23744235.2019.1653491. Epub 2019 Aug 21.

DOI:10.1080/23744235.2019.1653491

PMID:31433679

Abstract

摘要

相似文献

Antimicrobial activities of ceftazidime-avibactam, meropenem-vaborbactam and plazomicin against multidrug-resistant and - a pilot Bulgarian study.头孢他啶-阿维巴坦、美罗培南-巴坦和普拉佐米星对多重耐药菌的抗菌活性——一项保加利亚的试点研究

Infect Dis (Lond). 2019 Nov-Dec;51(11-12):870-873. doi: 10.1080/23744235.2019.1653491. Epub 2019 Aug 21.

Effects of KPC Variant and Porin Genotype on the Activity of Meropenem-Vaborbactam against Carbapenem-Resistant .KPC 变体和孔蛋白基因型对美罗培南-沃班坦对碳青霉烯类耐药的活性的影响。

Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02048-18. Print 2019 Mar.

Looking beyond ceftazidime-avibactam resistance in KPC-producing : activity of the novel meropenem-vaborbactam in combination with the old fosfomycin.超越产KPC菌株对头孢他啶-阿维巴坦的耐药性：新型美罗培南-巴罗巴坦与旧药磷霉素联合使用的活性

J Chemother. 2021 Dec;33(8):598-600. doi: 10.1080/1120009X.2021.1909939. Epub 2021 Apr 10.

In vitro synergistic activity of meropenem/vaborbactam in combination with ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae.美罗培南/巴罗巴坦与头孢他啶/阿维巴坦联合应用对产KPC肺炎克雷伯菌的体外协同活性。

J Antimicrob Chemother. 2019 May 1;74(5):1457-1459. doi: 10.1093/jac/dky557.

Activity of Meropenem-Vaborbactam against Pseudomonas aeruginosa and Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model.美罗培南-法硼巴坦对中性粒细胞减少症小鼠大腿感染模型中铜绿假单胞菌和鲍曼不动杆菌的活性。

Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01665-18. Print 2019 Jan.

Synergistic Effect of Ceftazidime-Avibactam with Meropenem against Panresistant, Carbapenemase-Harboring and Investigated Using Time-Kill and Disk Approximation Assays.头孢他啶-阿维巴坦与美罗培南对泛耐药、产碳青霉烯酶、被研究使用时间杀伤和药敏纸片近似法测定的菌株的协同作用。

Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02367-18. Print 2019 May.

In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan.在体外研究中，头孢地尔、头孢他唑巴坦/他唑巴坦、头孢他啶/阿维巴坦和其他比较药物对耐亚胺培南铜绿假单胞菌和鲍曼不动杆菌以及嗜麦芽窄食单胞菌的活性，这些细菌均与台湾的血流感染有关。

J Antimicrob Chemother. 2019 Feb 1;74(2):380-386. doi: 10.1093/jac/dky425.

Potency of Vaborbactam Is Less Affected than That of Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam.产生赋予对头孢他啶-阿维巴坦耐药性的 KPC-2 突变的菌株中，沃博巴坦的效力比阿维巴坦的效力受影响更小。

Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.01936-19.

Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.亚胺培南-西司他丁钠和美罗培南-法硼巴坦：两种新型碳青霉烯-β-内酰胺酶抑制剂复方制剂。

Drugs. 2018 Jan;78(1):65-98. doi: 10.1007/s40265-017-0851-9.

In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.头孢他啶/阿维巴坦单独或联合抗生素对多重耐药鲍曼不动杆菌分离株的体外活性。

J Glob Antimicrob Resist. 2019 Jun;17:137-141. doi: 10.1016/j.jgar.2018.12.004. Epub 2018 Dec 18.

引用本文的文献

Guava Leaf Extract Exhibits Antimicrobial Activity in Extensively Drug-Resistant (XDR) .番石榴叶提取物对广泛耐药菌（XDR）具有抗菌活性。

Molecules. 2024 Dec 28;30(1):70. doi: 10.3390/molecules30010070.

In vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam alone or in combination with polymyxin B against carbapenem resistant Acinetobacter baumannii.头孢他啶/阿维巴坦、亚胺培南/雷利巴坦和美罗培南/沃巴坦单独或联合多黏菌素 B 对碳青霉烯类耐药鲍曼不动杆菌的体外活性。

J Antibiot (Tokyo). 2023 Sep;76(9):540-547. doi: 10.1038/s41429-023-00631-0. Epub 2023 May 22.

Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion.耐碳青霉烯类革兰阴性菌感染的流行病学、耐药机制及治疗方案：专家小组意见

Antibiotics (Basel). 2022 Sep 17;11(9):1263. doi: 10.3390/antibiotics11091263.

Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing.革兰氏阴性多重耐药杆菌对头孢他啶/阿维巴坦、美罗培南/瓦博巴坦和亚胺培南/瑞来巴坦的耐药性：分子机制与药敏试验

Antibiotics (Basel). 2022 May 6;11(5):628. doi: 10.3390/antibiotics11050628.

Design of a Multi-epitope Vaccine Against Using Immunoinformatics Approach.基于免疫信息学方法设计一种抗……的多表位疫苗。（原文中“against”后缺少具体内容）

Int J Pept Res Ther. 2021;27(4):2417-2437. doi: 10.1007/s10989-021-10262-4. Epub 2021 Aug 28.

Meropenem-Vaborbactam in the Treatment of Acute Bacterial Infections.美罗培南-巴坦治疗急性细菌感染

J Clin Med. 2019 Oct 11;8(10):1650. doi: 10.3390/jcm8101650.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antimicrobial activities of ceftazidime-avibactam, meropenem-vaborbactam and plazomicin against multidrug-resistant and - a pilot Bulgarian study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献